Transplantation of kidneys from HCV viremic donors to HCV viremic recipients followed by early direct acting antiviral therapy without ribavirin

J Viral Hepat. 2019 Mar;26(3):407-409. doi: 10.1111/jvh.13042. Epub 2019 Jan 22.

Authors

Nikhil Kapila¹, Gianina Flocco¹, Kawtar Al Khalloufi², Xaralambos B Zervos²

Affiliations

¹ Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, Florida.
² Department of Transplant, Cleveland Clinic Florida, Weston, Florida.

PMID: 30449062
DOI: 10.1111/jvh.13042

No abstract available

Keywords: direct acting antiviral agents; hepatitis C; high-risk donors; kidney transplantation; waitlist management.

MeSH terms

Aged
Antiviral Agents / therapeutic use*
Female
Genotype
Hepacivirus / genetics
Hepatitis C / blood
Hepatitis C / drug therapy*
Hepatitis C / transmission
Humans
Kidney Transplantation / adverse effects
Kidney Transplantation / statistics & numerical data*
Male
Middle Aged
Retrospective Studies
Ribavirin
Tissue Donors*
Transplant Recipients*
Viremia / drug therapy*
Viremia / transmission

Substances

Antiviral Agents
Ribavirin